NewGenIvf Group (NIVF) terminated a binding term sheet with European Wellness Investment Holdings for a reverse merger.
European Wellness didn't meet the deadline to provide draft audited financial statements for 2023 and 2024, NewGenIvf said Monday in a statement.
The companies agreed to the binding term sheet on Dec. 11 with European Wellness planning to acquire almost 62% of NewGen. The $452 million transaction valued NewGenIvf stock at $3.20 a share.
European Wellness didn't immediately respond to a request for comment from MT Newswires.
Shares of NewGenIvf fell 34% in recent Monday trading.
Price: 0.61, Change: -0.33, Percent Change: -33.80
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.